remarks, in bookings Quarter Thank software sequential the you, prepared David. we your Call. in and trends improvement overall then Earnings XXXX Third and quarter, services. business with for everyone. John will third Thank Certara's Good saw questions. with and and both afternoon, will joining Certara I start stabilization growth you In take
of quarter with third the a same compared in X% year the ago. revenue was $XX.X period company million Total
declined last quarter versus and Software X% $XX.X was year last and million $XX.X versus million revenue services year. revenue in was and XX% grew the
uncertainty the that several than we there to experience seen areas across portfolio, business near-term the Over more a continue than accustomed we stabilization activity are the past of have though to. we some are in months, are
software and continue indications We see all customers. strong to across services for our tiers biosimulation of of interest
well executing plan and commercial during quarter are We operational the on earnings second the call. outlined
is platform. revenue form beginning converting early some and the across to already to alignment commercial bookings Our with enterprise take leads
As we organization, services which best we of be to to broadly. operating efficiency implemented improvements make the practices, continue more can identify
towards remain We execution we focused are initial heading and goals encouraged the quarter and by fourth revised the progress on for consistent year, XXXX. into into our
were of impacted quarter booked Reported $XX.X growth Our in some quarter. represented certain million, be timing third booked second XXXX. the third quarter versus with by of the some renewals bookings to was and the growth fourth bookings quarter software the having X% which software in
software as also continue segment headwinds. Software tiers double size average our digits. bookings and rise, in to growth impacted deal a this, Tier was customer the customer result of macroeconomic Despite to all across continuing industry X at grow
software encouraged return instills to lot future performance. our are value biosimulation, the to a see continue recognition smaller with us delivered of by biopharma bookings confidence of companies. We we among which a And with broad growth in for
initial developed product our of part continued an Since software has business key XXXX, XX's acquisition and Throughout Certara's its Pinnacle make software strategy, XXXX, capabilities. become integral XX and expand development team we on has progress features Pinnacle to in have that upon initiatives. software
data SDTM offering, involved a XXXX, for helps and the in sources which introduced standardize Throughout organize multiple We've also Pinnacle using process the have introduced exchange data from preparation component of formatting, CDISC submission. their key customers we and data automation management standard. XX's data
Pinnacle existing offering XX will applications. to Looking additional ahead, we complement believe opportunities there our be to expand
on Simcyp with at scientific tailored progress biosimulation Simcyp software formulation scientists problems. A Certara's family. product We version development. aimed make We in of working This continue our releasing advancing specific biopharmaceutics, by strategy newest of biostimulation launched expanding specifically to to the tools biosimulation also addition continues at targeted
in invest capability start efforts. we existing development AI. acquired development to intelligence announced questions AI And throughout designed AI-enhanced in continue the a product our we and client-specific answer of we early developing to within GPs Earlier artificial to Additionally, Certara Vyasa our kick the platform this software year, to deploy October, in-depth is platform. drug process. availability Certara
over science is is proprietary databases, XX documents and deep it and algorithm research proprietary powerful it the model. learning library a a million data includes unique yielding using this AI used because assets life by Certara client's built of and
writing in our craft drafting populate studies, co-author. messaging is our intelligence author the is submissions. regulatory uses deliver regulatory aid One integration AI advance called The artificial of content, summarize submission. Co-Author the and which recent to product auto software, aid in to can
or Certara quickly. and efficiencies to either AI are of and has the time. writing Certara substantial AI BXXX Use drive developed technology examples VIASA and using enhanced Co-Author, co-author potential over relatively of products are documentation be that all
and, early excited in the we still about are customers. is bring products learning it the and very our turn, to days intelligence artificial in that Certara potential While can AI, machine
Shifting our services now technology-driven to segment.
X% third quarter Third XXXX. quarter compared bookings with totaled of the $XX.X growth million representing
second quarter, During stable strong bookings X our quarter Tier customers. performance. compared biopharma observed a signs customers the environment with third we more initial with We spending of among our delivered
low tiers year our prior customers In the in grew improved compared and the period. addition, with digits services double X bookings sequentially among
year. the in confident of slightly period our bookings tracking Following compared services efforts. of consolidation regulatory sequentially, internal made commercial the business, revised Certara's changes the operations will grew expectations and ahead same improved coordination our last improve are and being with we
improved performance We integration will pace performance. with remain months, ongoing help improve the driving coming the of believe in the biosimulation and over the we committed business services business our regulatory to
services. in biosimulation services of performed also value customers Broader broad substantial saw for And activity services steadily we Biosimulation improving. and expectations, line with our continue industry in to the our throughout demand quarter. our our is a customer in see offering pickup
on expert clients and projects. consultants Certara's bringing value board, for significant gain their our By efficiency
expect the adoption we the with our and demand software, drive to we our pleased As for see trajectory increased biosimulation business. of and momentum services, are of current we
ability our lowering to in execute by value on biosimulation. to Certara's confident differentiated to plan are long-term our costs drug we offering customers we a prioritized can provide provides be accelerating and close, in due in completion. to project growth To lines the platform continues that drive time to
remains future look to and position for the ahead we As best fourth focus beyond, our quarter execution ourselves driving to consistent growth. on
to now call financial John review results. over turn I our the to